$ALKS 4 SEC Filings

Filed On	Filing
09 Oct 2026	Form 4: Reed Joshua, SVP, Chief Financial Officer Received 9,164 shares by exercise or conversion · Gave up 4,069 shares to cover exercise price or tax ($163K)
09 Oct 2026	Form 4: Whitaker Anne Clem, Director Granted 7,239 Restricted Stock Unit Award · Granted 17,998 Non Qualified Stock Option (Right to Buy)
02 Oct 2026	Form 4: Gaffin David Joseph, EVP, CLO, Alkermes, Inc. Sold 2,034 shares ($83.5K)
03 Sep 2026	Form 4: Gaffin David Joseph, EVP, CLO, Alkermes, Inc. Sold 2,034 shares ($97.7K)
01 Sep 2026	Form 4: Hopkinson Craig C., EVP R&D, Chief Medical Officer Received 5,000 shares by exercise or conversion ($123K) · Sold 9,000 shares ($423K)
17 Aug 2026	Form 4: Nichols Christian Todd, SVP, Chief Commercial Officer Sold 7,576 shares ($373K)
07 Aug 2026	Form 4: Jackson Blair Curtis, Director Granted 217,534 Employee Stock Option (Right to Buy)
03 Aug 2026	Form 4: snyderman nancy lynn Md, Director Received 44,472 shares by exercise or conversion ($2.08M) · Sold 44,472 shares ($2.24M)
03 Aug 2026	Form 4: Hopkinson Craig C., EVP R&D, Chief Medical Officer Received 5,000 shares by exercise or conversion ($122K) · Sold 9,000 shares ($437K)
03 Aug 2026	Form 4: Gaffin David Joseph, EVP, CLO, Alkermes, Inc. Sold 2,034 shares ($98.8K)
06 Jul 2026	Form 4: Gaffin David Joseph, EVP, CLO, Alkermes, Inc. Sold 2,034 shares ($110K)
01 Jul 2026	Form 4: Hopkinson Craig C., EVP R&D, Chief Medical Officer Received 5,000 shares by exercise or conversion ($96.7K) · Sold 9,000 shares ($464K)
12 Jun 2026	Form 4: Wright Christopher I, Director Sold 2,000 shares ($90.2K)
04 Jun 2026	Form 4: Gaffin David Joseph, EVP, CLO, Alkermes, Inc. Sold 2,034 shares ($87.6K)
01 Jun 2026	Form 4: Hopkinson Craig C., EVP R&D, Chief Medical Officer Received 5,000 shares by exercise or conversion ($96.7K) · Sold 9,000 shares ($375K)
29 May 2026	Form 4: Parisi Samuel Joseph, VP, Finance (Interim PAO) Received 16,217 shares by exercise or conversion ($316K) · Sold 16,217 shares ($687K)
22 May 2026	Form 4: Wright Christopher I, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award · Received 6,142 shares by exercise or conversion · 1 more
22 May 2026	Form 4: Wilson Frank Anders, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award · Received 6,142 shares by exercise or conversion · 1 more
22 May 2026	Form 4: snyderman nancy lynn Md, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award · Received 6,142 shares by exercise or conversion · 1 more
22 May 2026	Form 4: Mckeon Brian P, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award · Received 6,142 shares by exercise or conversion · 1 more

Comments